These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 21516426)

  • 1. Analysis of drug interactions.
    Bijnsdorp IV; Giovannetti E; Peters GJ
    Methods Mol Biol; 2011; 731():421-34. PubMed ID: 21516426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic combinations of anticonvulsant agents: what is the evidence from animal experiments?
    Jonker DM; Voskuyl RA; Danhof M
    Epilepsia; 2007 Mar; 48(3):412-34. PubMed ID: 17346245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low folate conditions may enhance the interaction of trifluorothymidine with antifolates in colon cancer cells.
    Temmink OH; Hoogeland MF; Fukushima M; Peters GJ
    Cancer Chemother Pharmacol; 2006 Jan; 57(2):171-9. PubMed ID: 16010590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ifosfamide-based drug combinations: preclinical evaluation of drug interactions and translation into the clinic.
    Vanhoefer U; Schleucher N; Klaassen U; Seeber S; Harstrick A
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):8-13. PubMed ID: 10697038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of human cytomegalovirus to two-drug combinations in vitro.
    Manion DJ; Vibhagool A; Chou TC; Kaplan J; Caliendo A; Hirsch MS
    Antivir Ther; 1996 Dec; 1(4):237-45. PubMed ID: 11324826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of drug combination analysis with isobolograms.
    Tallarida RJ
    J Pharmacol Exp Ther; 2006 Oct; 319(1):1-7. PubMed ID: 16670349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of combination chemotherapy: integration of nonlinear regression, curve shift, isobologram, and combination index analyses.
    Zhao L; Wientjes MG; Au JL
    Clin Cancer Res; 2004 Dec; 10(23):7994-8004. PubMed ID: 15585635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and sample size for evaluating combinations of drugs of linear and loglinear dose-response curves.
    Fang HB; Tian GL; Li W; Tan M
    J Biopharm Stat; 2009 Jul; 19(4):625-40. PubMed ID: 20183430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quantitative estimation of potentiating or inhibitory effects of similarly acting drugs in combination. Advantages of a dose-response curve method over the isoboles-method (author's transl)].
    Pöch G
    Arzneimittelforschung; 1981; 31(7):1135-40. PubMed ID: 7196763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical mixture toxicity testing with Vibrio fischeri: combined effects of binary mixtures for ten soft electrophiles.
    Dawson DA; Pöch G; Schultz TW
    Ecotoxicol Environ Saf; 2006 Oct; 65(2):171-80. PubMed ID: 16139365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating response to antineoplastic drug combinations in tissue culture models.
    Reynolds CP; Maurer BJ
    Methods Mol Med; 2005; 110():173-83. PubMed ID: 15901935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The postantibiotic effect induced by antimicrobial combinations.
    Gudmundsson S; Erlendsdóttir H; Gottfredsson M; Gudmundsson A
    Scand J Infect Dis Suppl; 1990; 74():80-93. PubMed ID: 2129068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells.
    Tyagi AK; Agarwal C; Chan DC; Agarwal R
    Oncol Rep; 2004 Feb; 11(2):493-9. PubMed ID: 14719089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Didanosine, interferon-alfa and ribavirin: a highly synergistic combination with potential activity against HIV-1 and hepatitis C virus.
    Klein MB; Campeol N; Lalonde RG; Brenner B; Wainberg MA
    AIDS; 2003 May; 17(7):1001-8. PubMed ID: 12700449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The rationale for drug combinations in the therapy of arterial hypertension].
    Salvetti A; Virdis A; Di Venanzio L
    Ann Ital Med Int; 1993 Oct; 8 Suppl():107S-110S. PubMed ID: 8117517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined effects in toxicology--a rapid systematic testing procedure: cadmium, mercury, and lead.
    Schubert J; Riley EJ; Tyler SA
    J Toxicol Environ Health; 1978; 4(5-6):763-76. PubMed ID: 731728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
    Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review.
    Wadler S; Schwartz EL
    Cancer Res; 1990 Jun; 50(12):3473-86. PubMed ID: 1692761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.